In this RACGP NewsGP article, Assoc Prof Simonis was asked to comment on research from Germany, which shows that children and adolescents are not immune to long-COVID. “ ….the difficulty ( with children) is that they can’t describe their symptoms like adults can, so you’re probably never going to get an accurate picture of what they’re experiencing,’ Dr Simonis said.
RACGP – ‘Long COVID risk similar for kids and adults: Study’
With Australia in the midst of a new wave of infections, research has revealed the extent of post-COVID morbidity in children and adolescents.
The research, published in PLOS Medicine, shows children, teenagers and adults are diagnosed with higher rates of new physical and mental health problems months after COVID infection.
Overall, children and adolescents with COVID were 30% more likely to have documented health problems over three months post-infection. Symptoms included malaise, fatigue, cough, chest pain, headache, anxiety, abdominal pain and depression.
Over the same period post diagnosis, adults with COVID were 33% more likely to have health problems, with symptoms including dyspnoea, chest pain, hair loss, fatigue, headache and smell/taste disturbance.
RACGP Expert Committee – Quality Care member, Associate Professor Magdalena Simonis told newsGP this is important research.
‘We are seeing more long COVID patients, and it can present in a variety of ways,’ she said.
In line with previous studies, the German researchers observed that incidence rates of long-term sequelae in children and adolescents with COVID were generally lower than those in adults, and appear to be less pronounced in absolute terms.
However, with high infection rates and upwards of 80% of the population having contracted the virus, the authors emphasise that post-COVID syndromes cannot be dismissed among children and adolescents.
Associate Professor Simonis reports common symptoms she sees in long COVID include atypical chest pains, palpitations, irregular cardiac rhythms, brain fog, a failure to feel refreshed after rest and reduced exercise tolerance.
Another common one is fatigue, which can be hard to pinpoint in children.
‘The difficulty is that they can’t describe their symptoms like adults can, so you’re probably never going to get an accurate picture of what they’re experiencing,’ Associate Professor Simonis said.
‘They don’t connect the less well-defined symptoms with what’s going on in their bodies, so something diffuse like fatigue can be harder to pinpoint.’
The German researchers used data covering nearly half of the population and spanning all of 2019 and 2020, comparing PCR-positive COVID patients to controls and the occurrence of pre-specified diagnoses entered into medical records at least three months post-infection.
They concluded that COVID diagnosis was associated with higher long-term demand for healthcare services as reflected in outpatient and inpatient diagnoses more than three months after confirmed infection.
And while children and adolescents appear to be less affected than adults, the findings are statistically significant for all age groups.
REC – QC member Associate Professor Paresh Dawda told newsGP ongoing research is needed.
‘We need to be open to the consequences of long COVID and what they may or may not be,’ he said.
‘We need to respond to patients as they present to us, but more importantly, we need to have a learning system where we are capturing the data and information to be able to make meaningful insights.’
Meanwhile, for the Australian context in 2022, Associate Professor Simonis said there has been a high burden of other respiratory viruses that could compound long COVID symptoms.
‘There are still many circulating viruses,’ she said. ‘Sometimes you do a swab for COVID but they have another virus like RSV or parainfluenza, and sometimes when you do the respiratory PCR swab you find they have COVID plus something else.
‘Another thing we see is [that] they had COVID before, but now we’re seeing another virus and it can be hard to know what is what.
‘With the change from lockdowns to open mingling, we may be seeing more kids who are succumbing to a variety of different viruses, and this can distort the picture, knowing which virus is causing what ongoing symptom.’
However, Associate Professor Simonis says long COVID provides an opportunity for GPs to do what they do best.
‘We know that COVID is different to other diseases – it’s not like a usual cold,’ she said.
‘We know it has a prothrombotic element and can cause microvascular disease, and as a result the recovery time can be different than your usual cold.
‘I offer them comprehensive care. It’s an opportunity to talk about lifestyle and about convalescence.
‘We don’t use that word much anymore. Before, with some conditions we expected a period of convalescence, which could be weeks or months. COVID has taught us that there is a convalescent period, but that doesn’t mean they won’t get better.
‘Patients need to turn to their GPs for an optimistic and holistic approach to their management. I remain optimistic.’
Source article and photo credit: https://www1.racgp.org.au/newsgp/clinical/long-covid-risk-similar-for-kids-and-adults-study
Magdalena is the President of the AFMW (2020-) and former President of VMWS (2013 & 2017-2020), National Coordinator AFMW, MWIA Scientific and Research Subcommittee co-Chair, MWIA Mentoring and Leadership, Special Interest Group, Chair
Magdalena’s deep engagements with the RACGP over many years includes chair of Women in General Practice, is currently on the RACGP Expert Committee Quality Care, prior to that on RACGP eHealth Expert Committee. She is a regular media spokesperson on numerous health issues, being interviewed most weeks by mainstream and medical media. Magdalena has represented the RACGP at senate enquiries and has worked on several National Health Framework reviews.
Both an RACGP examiner and University examiner she supervises medical students and undertakes general practice research. Roles outside of RACGP include the Strategy and Policy Committee for Breast Cancer Network Australia, Board Director of Women’s Health Victoria and Chair of their Strategy and Policy subcommittee and the AMA Victoria GP Network Committee.
Magdalena has presented at the United Nations as part of the Australian Assembly and was recently appointed the Australian representative to the World Health Organisation, World Assembly on COVID 19, by the Medical Women’s International Association (MWIA).